Sage Journals: Discover world-class research

Abstract

Spanish

French

OBJECTIVE:

To report a case of aripiprazole-responsive adult Asperger disorder.

CASE SUMMARY:

A 34-year-old white man with lifelong, disabling Asperger disorder and a 20-year history of failed psychotherapeutic and pharmacologic interventions was prescribed aripiprazole, with dramatic symptomatic improvement.

DISCUSSION:

Multiple prior pharmacologic efforts over several years aimed predominantly at altering serotonin and dopamine neurotransmission resulted in treatment failure due to intolerable adverse effects, exacerbation of underlying symptoms, or nonresponse. Aripiprazole, with a complex profile of neurotransmitter affinities, has produced significant core symptom changes. Improved sociability; increased self-awareness; reduced rigidity, anxiety, and irritability; and reduced preoccupation with circumscribed esoteric interests are among the effects noted.

CONCLUSIONS:

Previously intractable Asperger disorder symptoms in a 34-year-old man were ameliorated with aripiprazole.

Keywords

aripiprazole Asperger disorder

Get full access to this article

View all access options for this article.

References

Diagnostic and statistical manual of mental disorders. 4th ed. Washington, DC: American Psychiatric Association, 1994.

Volkmar

Klin

Diagnostic issues in Asperger syndrome. In: Klin

Volkmar

Sparrow

, eds. Asperger syndrome. New York: The Guilford Press, 2000:25–71.

Martin

Patzer

Volkmar

Psychopharmacological treatment. In: Klin

Volkmar

Sparrow

, eds. Asperger syndrome. New York: The Guilford Press, 2000:210–28.

Tantum

Adolescence and adulthood of individuals with Asperger syndrome. In: Klin

Volkmar

Sparrow

, eds. Asperger syndrome. New York: The Guilford Press, 2000:367–99.

Billberg

Billstedt

Autism and Asperger syndrome: coexistence with other clinical disorders. Acta Psychiatr Scand 2000;102:321–30.

Schultz

Romanski

Tsatsanis

Neurofunctional models of autistic disorder and Asperger syndrome. In: Klin

Volkmar

Sparrow

, eds. Asperger syndrome. New York: The Guilford Press, 2000:172–209.

Murphy

Critchley

Schmitz

McAlonan

VanAmelsvoort

Robertson

Asperger syndrome: proton magnetic resonance spectroscopy study of brain. Arch Gen Psychiatry 2002;59:885–91.

Kapur

Remington

Serotonin-dopamine interaction and its relevance to schizophrenia. Am J Psychiatry 1996;153:466–76.

Klin

Volkmar

Treatment and intervention guidelines. In: Klin

Volkmar

Sparrow

, eds. Asperger syndrome. New York: The Guilford Press, 2000:340–66.

10.

McDougle

Psychopharmacology. In: Cohen

Volkmar

, eds. Handbook of autism and pervasive developmental disorders. 2nd ed. New York: Wiley, 1997:707–29.

11.

Keck

Jr McElroy

Aripiprazole: a partial dopamine agonist D₂ receptor agonist antipsychotic. Expert Opin Investig Drugs 2003;12:655–62.

Aripiprazole in an Adult with Asperger Disorder

Abstract

OBJECTIVE:

CASE SUMMARY:

DISCUSSION:

CONCLUSIONS:

Keywords

Get full access to this article

References